Polaris Observatory C. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403.
Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis B virus infection in children and adolescents. The lancet Gastroenterology hepatology. 2019;4(6):466–76.
Campos-Outcalt D. Practice Alert: ACIP vaccine update. J Fam Pract. 2018;67(3):155–8.
Beasley RP, Stevens CE. Vertical transmission of HBV and interruption with globulin. Viral hepatitis 1978: 333–45.
Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981;2(8243):388–93.
Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 1983;3(2):135–41.
Reesink HW, Reerink-Brongers EE, Lafeber-Schut BJ, Kalshoven-Benschop J, Brummelhuis HG. Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet. 1979;2(8140):436–8.
Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099–102.
Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recommendations reports: Morbidity mortality weekly report Recommendations reports. 2005;54(Rr-16):1–31.
Hepatology CSo, Association CM. Consensus on the management of hepatitis B virus infection in women of childbearing age. J Clin Hepatol. 2018; Vol.34 No.6, Jun.2018.
Sheng QJ, Wang SJ, Wu YY, Dou XG, Ding Y. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study. Medicine. 2018;97(22):e10931.
Pan CQ, Duan Z, Dai E, et al. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. New England journal of medicine. 2016;374(24):2324–34.
Sun W, Zhao S, Ma L, et al. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission. BMC Gastroenterol. 2017;17(1):51.
Yang N, Meng Y, Zhou N, Lei L, Hu M. Cost-Benefitanalysis of Hepatitis B Vaccination Strategies for Preventing Mother-to-Child Transmission: A Decision Tree-Markov Model. Value in Health 2018; 21.
Wei KP, Zhu FC, Liu JX, et al. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study. Vaccine. 2018;36(2):256–63.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9, W64.
He T, Bai Y, Cai H, et al. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B. Hepatology international. 2018;12(2):118–25.
Chen T, Wang J, Qiu H, et al. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China. Medicine. 2018;97(27):e11406.
Zhu F, Deckx H, Roten R, Michiels B, Sarnecki M. Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China. Pediatr Infect Dis J. 2017;36(1):94–101.
Zhou S, Li T, Allain JP, et al. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers. Journal of medical virology. 2017;89(12):2130–7.
Pan CQ, Yi W, Liu M, Wan G, Hu YH, Zhou MF. Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B. Journal of viral hepatitis. 2017;24(3):246–52.
Kang W, Li Q, Shen L, et al. Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China. Vaccine. 2017;35(4):605–9.
Chen ZX, Gu GF, Bian ZL, et al. Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: A real-world prospective cohort study. J Infect. 2017;75(2):146–54.
Zhu FC, Sun KX, Pan HX, et al. The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10 µg recombinant yeast-derived Hepatitis B vaccine (Hep-KSC). Vaccine. 2016;34(24):2656–62.
Yin Y, Zhang P, Tan Z, Zhou J, Wu L, Hou H. The association of Pre-S/S gene mutations and hepatitis B virus vertical transmission. Hepatitis Monthly 2016; 16(3).
Wang C, Wang C, Jia ZF, et al. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine. 2016;95(34):e4390.
Tan Z, Yin Y, Zhou J, Wu L, Xu C, Hou H. Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy. Medicine. 2016;95(40):e4847.
Liu Y, Wang M, Yao S, et al. Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of hepatitis B virus. Hepatology research. 2016;46(3):E181-E8.
Tekin Koruk S, Batirel A, Kose S, et al. Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women. J Obstet Gynaecol Res. 2015;41(12):1870–6.
Deng Y, Wu W, Zhang D, et al. [The safety of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women after discontinuation]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2015;23(8):586–9.
Cuimin W, Guorong H, Hongxiu J, Naiying K, Yan W, Jinmei S. Comparison of combined immunization schemes influence on anti-HBs of babies born to mothers with highload hepatitis B virus infection. Chinese Journal of Hepatology. 2015;23(7):493–7.
Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62(2):375–86.
Zhang Z, Li A, Xiao X. Risk factors for intrauterine infection with hepatitis B virus. Int J Gynaecol Obstet. 2014;125(2):158–61.
Kang W, Ding Z, Shen L, et al. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province. China Vaccine. 2014;32(27):3362–6.
Yin Y, Wu L, Zhang J, Zhou J, Zhang P, Hou H. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. J Infect. 2013;66(5):447–52.
Xiang S, Feng-cai ZX-jZ. Wei-guo, X, et al. Comparing the efficacy of passive-active immunoprophylaxis using different doses of hepatitis B immunoglobulin in newborns of HBsAg positive mothers. ACTA UNIVERSITATIS MEDICINALIS NANJING(Natural Science). 2012;32(04):491–4.
Koumbi L, Bertoletti A, Anastasiadou V, et al. Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers. Cell Mol Immunol. 2010;7(6):454–8.
Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. Journal of viral hepatitis. 2009;16(2):94–103.
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. The Medical journal of Australia. 2009;190(9):489–92.
Deng Yu, Li Juan, Li WeiQun, Qian Z. Comparison of the effects of different doses of hepatitis B immunoglobulin in blocking mother-to-child transmission of hepatitis B virus. JOURNAL OF COMMUNITY MEDICINE. 2008;6(13):30–1.
Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet. 2007;96(3):167–70.
Yuan J, Lin J, Xu A, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. Journal of viral hepatitis. 2006;13(9):597–604.
Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J. 2002;115(10):1510–2.
Kato H, Nakata K, Hamasaki K, et al. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine. 1999;18(7–8):581–7.
Liu JF, Yao NJ, Chen TY, et al. Prevalence of mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis. Journal of hepatology. 2019;70:E123-E4. http://dx.doi.org/10.1016/S0618-8278(19)30217-8.
Li XM, Yang YB. HY H. Interruption of HBV intrauterine transmission: a clinical study. World Journal of Gastroenterology 2003 World Journal of Gastroenterology. 2003;9(7):1501–3.
Lu Y, Liang XF, Wang FZ, et al. Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers. Vaccine. 2017;35(1):40–5.
Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70(2):396–404.
Adkins B. T-cell function in newborn mice and humans. Immunology today. 1999;20(7):330–5.
Guo Z, Shi XH, Feng YL, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. Journal of viral hepatitis. 2013;20(5):317–21.
Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World journal of gastroenterology. 2004;10(21):3215–7.